PARIS & BOULDER, Colo., October 05, 2021–(BUSINESS WIRE)–Regulatory Information:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an modern firm that deploys its DSG® (Dynamic Surgical Steering) sensing expertise to safe and streamline the location of bone implants, pronounces that it has obtained clearance from ANVISA (Agência Nacional de Vigilância Sanitária), the federal government regulatory authority, for authorization to promote its DSG Join merchandise in Brazil.
As introduced in June, the obtention of ANVISA clearance was the final step within the registration means of SpineGuard’s DSG Join platform in Brazil after acquiring ANATEL (Agência Nacional De Telecomunicações) certification in March and INMETRO (The Nationwide Institute of Metrology, Standardization, and Industrial High quality) certification in June.
“Having efficiently finalized the registration course of, we will now begin promoting DSG Join in Brazil, the primary marketplace for spinal units in Latin America. A number of distributors have been already appointed to cowl the primary Brazilian states with agency orders secured. The coaching of those distributors and their surgeon prospects would be the subsequent precedence within the coming weeks,” stated Patricia Lempereur, Gross sales & Advertising and marketing Director, Worldwide of SpineGuard.
Based in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an modern firm deploying its proprietary radiation-free actual time sensing expertise DSG® (Dynamic Surgical Steering) to safe and streamline the location of implants within the skeleton. SpineGuard designs, develops and markets medical units which were utilized in over 85,000 surgical procedures worldwide. Seventeen research revealed in peer-reviewed scientific journals have demonstrated the a number of advantages DSG® presents to sufferers, surgeons, surgical employees and hospitals. Constructing on these stable fundamentals and several other strategic partnerships, SpineGuard has expanded its expertise platform in a disruptive innovation: the « sensible » pedicle screw launched late 2017 and is broadening the scope of purposes in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.
For additional data, go to www.spineguard.com
The SpineGuard securities is probably not supplied or offered in the USA as they haven’t been and won’t be registered below the Securities Act or any United States state securities legal guidelines, and SpineGuard doesn’t intend to make a public supply of its securities in the USA. That is an announcement and never a prospectus, and the knowledge contained herein does and shall not represent a suggestion to promote or the solicitation of a suggestion to purchase, nor shall there be any sale of the securities referred to herein in the USA during which such supply, solicitation or sale can be illegal previous to registration or exemption from registration.
View supply model on businesswire.com: https://www.businesswire.com/news/home/20211005005980/en/
CEO & Chairman
Tel: +33 1 45 18 45 19
Tel: +33 1 45 18 45 19
Investor Relations & Monetary Communication
Mathilde Bohin / Pierre Laurent
Tel.: +33 1 44 71 94 94